145 related articles for article (PubMed ID: 24128829)
21. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
22. Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database.
Kutikov A; Mallin K; Canter D; Wong YN; Uzzo RG
J Urol; 2011 Sep; 186(3):805-10. PubMed ID: 21788046
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of adrenal cortical carcinoma in the United States.
Paton BL; Novitsky YW; Zerey M; Harrell AG; Norton HJ; Asbun H; Kercher KW; Heniford BT
Surgery; 2006 Dec; 140(6):914-20; discussion 919-20. PubMed ID: 17188138
[TBL] [Abstract][Full Text] [Related]
24. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
[TBL] [Abstract][Full Text] [Related]
25. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
26. Surgical resection of synchronously metastatic adrenocortical cancer.
Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
[TBL] [Abstract][Full Text] [Related]
27. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
28. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
Livhits M; Li N; Yeh MW; Harari A
Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
[TBL] [Abstract][Full Text] [Related]
29. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.
Stojadinovic A; Ghossein RA; Hoos A; Nissan A; Marshall D; Dudas M; Cordon-Cardo C; Jaques DP; Brennan MF
J Clin Oncol; 2002 Feb; 20(4):941-50. PubMed ID: 11844815
[TBL] [Abstract][Full Text] [Related]
30. Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
Hammad AY; Yen TWF; Carr AA; Evans DB; Wang TS
J Surg Res; 2017 Jun; 213():138-146. PubMed ID: 28601306
[TBL] [Abstract][Full Text] [Related]
31. Operative intervention for recurrent adrenocortical cancer.
Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
[TBL] [Abstract][Full Text] [Related]
32. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
[TBL] [Abstract][Full Text] [Related]
33. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
[TBL] [Abstract][Full Text] [Related]
34. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
[TBL] [Abstract][Full Text] [Related]
35. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
36. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
37. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
38. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
Amini N; Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):126-33. PubMed ID: 26282907
[TBL] [Abstract][Full Text] [Related]
39. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
[TBL] [Abstract][Full Text] [Related]
40. Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma.
Suman P; Calcatera N; Wang CH; Moo-Young TA; Winchester DJ; Prinz RA
Am J Surg; 2017 Oct; 214(4):748-751. PubMed ID: 28233539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]